MAPT and Alzheimer disease: In vitro studies suggest that tau and amyloid-beta protein can switch a healthy astrocyte into one with a senescent phenotype [31,32] and Alzheimer’s disease patients show greater senescence than their age-matched counterparts, indicating that senescent astrocytes accumulate with normal aging and further increase with the onset of AD [31].